The good news just keeps pouring in: http://www.addextherapeutics.com/investors/press-releases/news-details/article/addex-reports-top-line-data-from-a-successful-phase-2a-clinical-study-with-adx71149-in-schizophrenia/ Followed by an upgrade by at least one analyst: 05-11-2012 09:57 RESEARCH ALERT-Addex Therapeutics: Jefferies raises target price * Jefferies raises target price to SFR 22 from SFR 18; rating buy